MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Beispiel ClinicalImpression: MII PR MTB Behandlungsepisode Beispiel

German

Profile: MII PR MTB Behandlungsepisode version: 2027.0.0-ballot.1

MII EX MTB Leitlinienbehandlung Status: MII CS Leitlinienbehandlung Status: exhausted (Leitlinien ausgeschöpft)

status: Completed

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

effective: 2023-03-01 --> 2023-05-31

problem: Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet

investigation

code: Eastern Cooperative Oncology Group scale for physical assessment (assessment scale)

item: Observation ECOG performance status

investigation

code: Molecular testing, diagnostic (procedure)

item: Diagnostic Report for 'Genetic analysis report' for '->Kim Musterperson (no stated gender), DoB: 1956-03-14'

investigation

code: Anatomic pathology procedure (procedure)

item: Diagnostic Report for 'Pathology synoptic report' for '->Kim Musterperson (no stated gender), DoB: 1956-03-14'

investigation

code: Was consent given

item: Observation Was consent given

supportingInfo: